Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Hearing Loss Among Patients With Multiple Sclerosis (Pwms): A Systematic Review and Meta-Analysis Publisher Pubmed



Mirmosayyeb O1, 2 ; Naderi M1, 2 ; Raeisi S2 ; Ebrahimi N1, 2 ; Ghaffary EM2 ; Afsharisafavi A2, 3 ; Barzegar M1, 2 ; Shaygannejad V1, 2
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Neurology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
  2. 2. Isfahan Neurosciences Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
  3. 3. Department of Biostatistics and Epidemiology, Faculty of Health, North Khorasan University of Medical Sciences, Bojnurd, Iran

Source: Multiple Sclerosis and Related Disorders Published:2022


Abstract

Background: Multiple sclerosis (MS) is a kind of autoimmune disorder that has swept more than 2 million people worldwide and has caused multiple disabilities in the patients. Hearing loss(HL) is also one of the disabilities that numerous patients with multiple sclerosis (PwMS) experience. Methods: We searched four databases: PubMed (Medline), Scopus, Web of Science, and Embase, from 1970 to July 2021. The gray literature containing the conference abstracts, review studies, and references of the articles was also investigated. We included any studies that reported PwMS with HL. Results: Out of 1875 articles, 1042 articles remained following eliminating duplicates. Afterward, all articles were screened, and 953 were eliminated based on exclusion criteria. Full texts of 89 articles were collected. Finally, eight articles were selected based on inclusion and exclusion criteria. The pooled prevalence of HL in PwMS was 1.1% (95% CI: [0.2%, 2.4%]; I2=80.11%; p<0.001) among 5187 MS population. Conclusion: Our analysis suggests that MS might increase the risk of HL, and it might be an indicator for MS diagnosis. More research with larger sample sizes is required. © 2022
Other Related Docs
10. Multiple Sclerosis in Isfahan, Iran, International Review of Neurobiology (2007)
17. Covid-19 Among Patients With Multiple Sclerosis a Systematic Review, Neurology: Neuroimmunology and NeuroInflammation (2021)
22. Environmental Risk Factors for Multiple Sclerosis: A Case-Control Study in Kerman, Iran, Iranian Journal of Nursing and Midwifery Research (2018)
27. Diagnosis and Management of Multiple Sclerosis in Children, Iranian Journal of Child Neurology (2016)
29. Serum Mercury Level and Multiple Sclerosis, Biological Trace Element Research (2012)
41. The Association Between Multiple Sclerosis and Migraine: A Meta-Analysis, Multiple Sclerosis and Related Disorders (2023)
43. Anti-Cd20 Therapies for Pediatric-Onset Multiple Sclerosis: A Systematic Review, Multiple Sclerosis and Related Disorders (2024)
44. Prevalence of Familial Multiple Sclerosis in Isfahan, Iran, Journal of Isfahan Medical School (2011)